ROCKWELL MEDICAL, INC. (RMTI)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Net sales | 16,071 | 18,914 | 28,316 | 25,832 |
| Cost of sales | 13,568 | 15,872 | 22,077 | 21,282 |
| Gross profit | 2,503 | 3,042 | 6,239 | 4,550 |
| General and administrative | 3,280 | 3,691 | 3,577 | 3,449 |
| Research and product development | - | - | - | - |
| Selling and marketing | 572 | 711 | 726 | 586 |
| Operating (loss) income | -1,349 | -1,360 | 1,936 | 515 |
| Interest income | 69 | 66 | 30 | 9 |
| Interest expense | 276 | 277 | 302 | 232 |
| Realized gain on available-for-sale investments | 64 | 56 | - | 51 |
| Total other expense, net | -143 | -155 | -272 | -172 |
| Net (loss) income | -1,492 | -1,515 | 1,664 | 343 |
| Basic net (loss) income per share (in dollars per share) | -0.05 | -0.04 | 0.05 | 0.01 |
| Basic weighted average shares outstanding (in shares) | 34,311,306 | 34,107,640 | 31,551,805 | 30,451,622 |
| Diluted net (loss) income per share (in dollars per share) | -0.05 | -0.04 | 0.04 | 0.01 |
| Diluted weighted average shares outstanding (in shares) | 34,311,306 | 34,107,640 | 32,420,168 | 32,033,776 |